Products

TraceEntry uses AI to categorize bank transactions in minutes instead of hours. Upload your client's CSV or Excel bank export, and our AI categorizes transactions by vendor with 95% accuracy. Built by an accountant for accountants. We understand Chart of Accounts, GAAP categories, and real bookkeeping workflows. Key features: - AI categorization with 95% accuracy - 22 industry-specific templates (restaurants, contractors, medical, retail, etc.) - Processes by unique vendor, not transaction-by-

64x Bio is a biotechnology company dedicated to revolutionizing the manufacturing of cell and gene therapies by developing scalable solutions that enhance production efficiency and reduce costs. Their proprietary VectorSelect™ platform utilizes high-throughput genome engineering and screening technologies, combined with computational tools, to create optimized mammalian cell lines for viral vector production. This innovation addresses critical bottlenecks in the industry, enabling pharmaceutical

Verge Genomics is a clinical-stage biotechnology company revolutionizing drug discovery by integrating artificial intelligence (AI) with human genomic data. Their proprietary CONVERGE® platform utilizes extensive multi-omic datasets derived directly from human tissues to identify and validate therapeutic targets, particularly for neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS) and Parkinson's disease. By focusing on human data from the outset, Verge aims to enhance the eff

Gallio PRO is software for automated anonymization (face and license plate blurring) in photo & video materials. Its main purposes are privacy protection and GDPR compliance. Compared to similar solutions it works as a desktop app, fully on-premise, and does not use cloud computing which involves sending sensitive data to third-party servers.

With the Electronic PDF Parsing Module for SoftWorks AI's Trapeze for Forms Processing, organizations can expect to achieve a 90-100% text confidence factor on average, allowing for greater auto-validation rates and a faster, more efficient workflow. For example, if half of an organization's documents are native PDF files, this module can increase total auto-validation rates by 30-50%.

With SoftWorks AI's Trapeze for mortgage automation, packets can be assembled, classified and prioritized in a streamlined manner with exceptional accuracy rates. It also auto-validates critical data from the loan packets so that users can approve or deny loan applications with as little time and effort possible, improving turnaround time and helping financial institutions acquire more profitable loans in an efficient manner.

Rhizome AI is a generative AI platform that transforms how biotech and life sciences teams access and interpret regulatory and clinical information. It allows users to instantly find what the FDA, EMA, and other health authorities have said about therapies, approvals, and trials, delivering verified insights in seconds instead of days. The platform integrates data from FDA and EMA pre-approval therapeutics databases, CTIS, ClinicalTrials.gov, and other key sources. All data is refreshed at the s

RxCrossroads by McKesson is a comprehensive service provider dedicated to supporting pharmaceutical and biotechnology manufacturers throughout the product lifecycle. Specializing in commercialization solutions, RxCrossroads offers a suite of services designed to enhance patient access, adherence, and overall health outcomes. By integrating deep therapeutic expertise with innovative technology, RxCrossroads streamlines the journey from product launch to patient care, ensuring therapies reach the

A partner data acquisition and harmonization platform.

An AI-ML based data contextualization platform.

Promotion Effectiveness enables enterprises to measure and fully understand the effectiveness of trade promotions. It makes sense of complex and disparate point-of-sale data, to deliver a more accurate analysis across multiple metrics (spend ratio, volume uplift, amongst others). Built on a light weight architecture, it ensures computations and analysis can be run across large data sets.

Parallel Bio is revolutionizing drug discovery by integrating human immune organoids with artificial intelligence to develop therapies that are effective from the outset. Traditional drug development often relies on animal models, which frequently fail to predict human responses accurately, leading to high failure rates and prolonged timelines. Parallel Bio addresses this challenge by creating in-vitro replicas of human lymph nodes—immune organoids—that mimic the human immune system's structure

BenevolentAI is a pioneering AI-enabled drug discovery company that integrates advanced artificial intelligence with scientific expertise to accelerate the development of novel treatments for complex diseases. By leveraging its proprietary Benevolent Platform™, the company analyzes vast biomedical datasets to uncover new insights into disease biology, identify promising drug targets, and enhance the probability of clinical success. This approach streamlines the drug discovery process, reducing b

Immunai is a biotechnology company dedicated to mapping the human immune system with unprecedented scale and resolution. By integrating single-cell genomics with advanced machine learning algorithms, Immunai aims to accelerate the discovery and development of novel immune-related therapeutics. Their platform provides comprehensive insights into immune mechanisms, facilitating smarter decision-making in drug development and personalized medicine. Key Features and Functionality: - Target Discove

BIOVIA BioPharma is a comprehensive suite of software solutions designed to accelerate innovation in the biopharmaceutical industry. By integrating advanced modeling, simulation, and data analytics, it enables researchers and developers to streamline the discovery, design, and optimization of biotherapeutics. The platform supports end-to-end workflows, from initial target identification to final product formulation, enhancing collaboration and efficiency across multidisciplinary teams. Key Feat

PostEra is a biotechnology company leveraging machine learning to revolutionize medicinal chemistry and expedite the discovery of new medicines. Their proprietary AI platform, Proton, addresses the complexities of drug development by enhancing the design and synthesis of small molecules, thereby accelerating the path from concept to clinical trials. Key Features and Functionality: - Proton AI Platform: Utilizes advanced machine learning algorithms to optimize medicinal chemistry processes, imp

QuantHealth is an AI-driven healthcare company revolutionizing drug development through advanced clinical trial simulations. Founded in 2020, the company has successfully simulated over 350 clinical trials with an impressive 85% accuracy rate. Its cutting-edge in-silico platform enables pharmaceutical and biotechnology companies to accelerate and de-risk their development processes, bringing more effective treatments to patients faster and more affordably. Key Features and Functionality: - Com

Momentm is a dedicated Health & Human Services Transportation brand, emerging with 30+ years of prior experience from TripSpark and Trapeze. This new brand is a reflection of our commitment to addressing a key social determinant of health (SDOH), namely non-emergency medical transportation (NEMT), for many market segments including Managed Care Organizations, brokers, transportation providers, PACE, IDD and health groups. NovusMED is our core human and health services transportation software

Teameet is a comprehensive video conferencing platform designed to facilitate seamless virtual meetings and collaborations. It offers a user-friendly interface that supports high-quality audio and video communication, making it suitable for both personal and professional use. Key Features and Functionality: - High-Quality Audio and Video: Ensures clear and uninterrupted communication during meetings. - Screen Sharing: Allows participants to share their screens for presentations and collaborati

TradeKey.com was established in 2005 with the aim to facilitate global trade and bring buyers and sellers from all around the world to one common platform. With a capital investment of US $20 Million - TradeKey.com is world's leading marketplace which connects traders with worldwide wholesalers, buyers, importers & exporters, manufacturers and distributors in over 220 countries, quickly and cost effectively. TradeKey.com is world's first B2B marketplace that earned ISO 9001 Quality Managemen